MolGen - PurePrep 96 in action

MolGen  to  showcase  at SLAS conference in Boston, US

MolGen  to  showcase  high throughput testing,  industry systems, reagents,  consumables  and complete workflows at SLAS conference in Boston, US

Veenendaal, January 27th, 2022 – MolGen B.V. of Veenendaal (NL) is excited to announce its participation in SLAS 2022, February 5-9. SLAS 2022, organized by SLAS international conference and exhibition to highlight life science discoveries, research and innovations in laboratory technology. With 80 scientific talks and exhibitions, it brings a unique opportunity to inspire life science researchers to share discovery and thought-provoking research, to connect with developers and top-tier providers of laboratory automation technology, and advance scientific innovation. MolGen is looking forward to being a part of this premier international conference to share its innovative diagnostic workflows and connect to the esteemed network of academic, industry, government life science researchers and laboratory automation technology providers.

MolGen is using this conference as an opportunity to showcase its high-tech laboratory automation technology, customized diagnostic workflow and its latest products and services to technology professionals and life science researchers. During this conference, MolGen will display its complete diagnostics workflow and molecular automation product offerings for human diagnostics and pharmaceutical sciences that are available worldwide.

In the areas of human diagnostics, industry and laboratory sciences, MolGen offers integrated state-of-the-art molecular purification products and systems that achieve greater efficiency, automation and scaling-up in human disease testing and diagnosis. Its extraction and testing solutions, products and equipment are designed to achieve high throughput, increased automation, reduced time to result, high yields and effective reproducibility. MolGen’s systems and consumables are versatile, efficient, highly accurate, reliable and universally applicable to empower next-generation research genetics and improve the health and wellbeing of all.

“Attending the SLAS conference will be the perfect opportunity to share our customisable laboratory workflows. Our products ensure greater efficiency, automation and safety as a standard, and solve the problem of lab personnel shortage by allowing high throughput robotics for large-scale molecular testing. by allowing high throughput for large-scale molecular diagnostics. Solving the need for high throughput testing, our scalable reagents, systems and workflows represent true innovations in laboratory technology that will transform the day-to-day of professional laboratories worldwide,“ said Niels Kruize, MolGen CCO.

MolGen is a global total solution provider of innovative extraction DNA/RNA technology, systems, products and kits for human and animal diagnostics, the agriculture and biotech industries. MolGen’s, systems, reagents and consumables reduce hands-on time and increase productivity while maintaining high yields and reproducibility. From sample to result, MolGen is challenging the status quo in molecular diagnostics by offering platform stand-alone systems and consumables. MolGen’s portfolio offers high-quality, adaptable, and safe workflows, which can be customised to meet customers’ specific needs.

MolGen Takes Part at SLAS Europe Fair in Dublin, Ireland

MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA / RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the SLAS Europe Fair, in Dublin, on the 24-27th of May 2022.

read more

Multiplex Respiratory viruses’ RT-qPCR kit: MoaA RT-q PCR kit by MolGen

The rapid and global spread of SARS-CoV-2 has impacted society heavily. This pandemic has placed both the world economy and health under pressure. To provide relief to populations, governments and businesses during these difficult times, MolGen has developed a high throughput, efficient and safe testing framework.

read more